Qtick
Sign in

Cencora, Inc. (COR) Competitors & Peers

The 5 companies closest to Cencora, Inc. on the factors that matter — each comparable links to its own dossier. Numbers are code-computed, never estimated.

How we identify peers ↗

TickerRelationshipPriceComparables
MCKCompetitor$879.87P/E 23.6RSI 62Cap 102.6 B
CAHCompetitor$237.18P/E 36.1RSI 59Cap 55.5 B
HSICPeer$89.94P/E 26.2RSI 66Cap 10.2 B
EBOSFPeer$23.75P/E 34.9RSI 100Cap 4.9 B
EBOSYPeer$26.00P/E 17.7RSI 17Cap 2.7 B

How these relationships were derived

Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.

Confirmed relationships (cited)

Sourced from a public filing or disclosure — each links to its origin.

  • WBASupplier

    Cencora is the primary pharmaceutical wholesale distributor for Walgreens, representing 25% of Cencora's total revenue. WBA also holds a strategic equity stake in Cencora.

    Confirmed — SEC filing / public disclosuresec.gov
  • EVRNTHSupplier

    Evernorth Health Services (CVS Health's PBM subsidiary) is Cencora's second-largest customer at approximately 13% of fiscal 2025 revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • GILDSupplier

    Cencora is one of Gilead's three primary wholesale distributors, part of the ~90% US gross product sales concentration.

    Confirmed — SEC filing / public disclosuresec.gov
  • BMYSupplier

    Cencora is Bristol-Myers Squibb's second-largest wholesale distributor, accounting for approximately 19% of gross revenues in FY2025.

    Confirmed — SEC filing / public disclosuresec.gov
  • AMGNSupplier

    Amgen distributes biologics through Cencora as one of three major wholesalers, each exceeding 10% of Amgen's gross revenues.

    Confirmed — SEC filing / public disclosuresec.gov
  • ORGOCustomer

    Cencora (formerly AmerisourceBergen) is a major distributor for Organogenesis, representing approximately 19% of gross revenues in FY2025.

    Confirmed — SEC filing / public disclosuresec.gov
  • CISupplier

    Own 10-K customer-concentration disclosure: ExpressScriptsInc = 13% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • JNJSupplier

    Cencora is JNJ's third-largest wholesale distributor, representing approximately 11.1% of consolidated gross revenues.

    Confirmed — SEC filing / public disclosuresec.gov
  • LLYSupplier

    Cencora is Eli Lilly's second-largest wholesale distributor, representing approximately 19% of consolidated gross revenues in FY2025.

    Confirmed — SEC filing / public disclosuresec.gov
  • ABBVSupplier

    Cencora is one of AbbVie's three primary U.S. wholesalers that collectively distribute U.S. pharmaceutical sales.

    Confirmed — SEC filing / public disclosuresec.gov

Model-inferred relationships (unverified)

Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.

  • CAHCompetitor

    Top 3 US drug distributors.

    Model-inferred, unverified — treat as a lead, not evidence
  • MCKCompetitor

    Top 3 US drug distributors.

    Model-inferred, unverified — treat as a lead, not evidence
  • NVOSupplier

    Cencora is Novo Nordisk's second-largest US wholesale distributor, representing approximately 17% of total global net sales in 2024.

    Model-inferred, unverified — treat as a lead, not evidence
  • ABTSupplier

    Cencora (formerly AmerisourceBergen) distributes Abbott's pharmaceuticals and nutritional lines to hospitals and specialty pharmacies.

    Model-inferred, unverified — treat as a lead, not evidence
  • MDTSupplier

    Cencora distributes Medtronic specialty medical devices to specialized clinics and surgical centers.

    Model-inferred, unverified — treat as a lead, not evidence
  • EWSupplier

    Cencora distributes Edwards specialty transcatheter heart valves to clinical accounts.

    Model-inferred, unverified — treat as a lead, not evidence
  • BSXSupplier

    Cencora (AmerisourceBergen) distributes Boston Scientific's medical technologies and clinical supplies globally.

    Model-inferred, unverified — treat as a lead, not evidence
  • DXCMSupplier

    Cencora serves as a principal wholesale distribution channel delivering DexCom CGM systems to international and domestic healthcare networks.

    Model-inferred, unverified — treat as a lead, not evidence
  • PENSupplier

    Cencora (AmerisourceBergen) distributes Penumbra's neurovascular and peripheral thrombectomy devices to clinics and hospital pharmacies.

    Model-inferred, unverified — treat as a lead, not evidence
  • ZBHSupplier

    Cencora (formerly AmerisourceBergen) acts as a distributor of Zimmer Biomet's orthopedic and medical products to institutional healthcare providers.

    Model-inferred, unverified — treat as a lead, not evidence
  • SNNSupplier

    Cencora acts as a wholesale distributor of Smith & Nephew's medical technologies and clinical consumables to healthcare providers.

    Model-inferred, unverified — treat as a lead, not evidence
  • BDXSupplier

    Cencora serves as a major distributor for BD's clinical products, pharmaceutical delivery systems, and medical supplies.

    Model-inferred, unverified — treat as a lead, not evidence
  • MRKSupplier

    Cencora distributes Merck.

    Model-inferred, unverified — treat as a lead, not evidence
  • PFESupplier

    Cencora distributes Pfizer products globally.

    Model-inferred, unverified — treat as a lead, not evidence
  • JNJSupplier

    Cencora distributes J&J products.

    Model-inferred, unverified — treat as a lead, not evidence
  • PFESupplier

    Cencora is one of Pfizer's three primary wholesale distributors, providing pharmaceutical distribution across specialty and primary care channels.

    Model-inferred, unverified — treat as a lead, not evidence
  • MRKSupplier

    Cencora is one of Merck's three primary wholesale distributors in the US market.

    Model-inferred, unverified — treat as a lead, not evidence